195305-79-4

Basic information

• Product Name: Benzoic acid, 3-(dimethoxyphenylmethyl)-, methyl ester
• CAS NO: 195305-79-4
• Molecular Formula: C17H18O4
• Molecular Weight: 286.328
• Mol File: 195305-79-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-(dimethoxyphenylmethyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-(dimethoxyphenylmethyl)-, methyl ester(195305-79-4)
• EPA Substance Registry System: Benzoic acid, 3-(dimethoxyphenylmethyl)-, methyl ester(195305-79-4)

Safety Data

• Hazardous Substances Data: 195305-79-4(Hazardous Substances Data)

Upstream product

• 579-18-0 3-benzoylbenzoic acid 
• 21204-86-4 m-benzoylbenzoic acid methyl ester 
• 149-73-5 trimethyl orthoformate 

Downstream Products

• 195305-64-7 (3-Benzoyl-phenyl)-bis-methylsulfanyl-thioacetic acid S-methyl ester 
• 195305-52-3 1-(3-Benzoyl-phenyl)-2,2,2-tris-methylsulfanyl-ethanone 
• 197313-97-6 1-[3-(Dimethoxy-phenyl-methyl)-phenyl]-2,2,2-tris-methylsulfanyl-ethanone 
• 467225-74-7 S-butyl bis(butylsulfanyl)(3-benzoylphenyl)thioacetate 
• 467225-78-1 S-butyl α-(3-benzoylphenyl)-α-(butylsulfanyl)thiopropionate 
• 467225-84-9 S-butyl α-(3-benzoylphenyl)thiopropionate 
• 22071-15-4 ketoprofen 

Relevant articles and documents

8-Aza-11-deoxy prostaglandin analogues

This invention relates to compounds which are generally EP4 receptor agonists and which are represented by Formula I: wherein A is a —CH2—CH2—, or —CH═CH—; B is absent, an aryl, or heteroaryl group; R1 is alkyl, alkenyl, alkynyl, cycloalkylalkyl, heterocyclylalkyl, aryl, arylalkyl or heteroaryl, when B is aryl or heteroaryl and R3, R4, R5 and R6 are not simultaneously hydrogen, or R1 is heterocyclylalkyl, aryl, or heteroaryl when B is absent and R3, R4, R5 and R6 are simultaneously hydrogen; and the other substituents are as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds, methods for their use as therapeutic agents, and methods of preparation thereof.